We are live on ! Find out more
ANIK icon

Anika Therapeutics

162 hedge funds and large institutions have $465M invested in Anika Therapeutics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 49 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

37% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 49

11% more capital invested

Capital invested by funds: $417M → $465M (+$47.4M)

6% more funds holding

Funds holding: 153162 (+9)

1% more call options, than puts

Call options by funds: $4.03M | Put options by funds: $4M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
162
Holders Change
+9
Holders Change %
+5.88%
% of All Funds
4.66%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
67
Reduced
49
Closed
15
Calls
$4.03M
Puts
$4M
Net Calls
+$28K
Net Calls Change
+$1.87M
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$44.1M +$918K +20,644 +2%
BFA
2
BlackRock Fund Advisors
California
$32M +$1.02M +22,987 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$25.4M +$3.37M +75,752 +16%
BIT
4
BlackRock Institutional Trust
California
$22M -$1.46M -32,900 -6%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$18M +$3.28M +73,700 +23%
Allianz Asset Management
6
Allianz Asset Management
Germany
$17.7M -$1.73M -38,944 -9%
Renaissance Technologies
7
Renaissance Technologies
New York
$17M -$3.34M -75,000 -17%
BIM
8
Bogle Investment Management
Massachusetts
$13.2M
State Street
9
State Street
Massachusetts
$13M +$477K +10,735 +4%
TSW
10
Thompson Siegel & Walmsley
Virginia
$12.2M +$11.7M +262,822 +32,853%
GAM
11
Gotham Asset Management
New York
$10.9M +$10.5M +235,399 New
PCM
12
Portolan Capital Management
Massachusetts
$10.1M +$1.83M +41,141 +23%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$9.56M +$1.25M +28,163 +16%
NI
14
Numeric Investors
Massachusetts
$9.25M +$2.51M +56,357 +39%
SIMG
15
Stephens Investment Management Group
Texas
$8.93M +$1.44M +32,490 +20%
AAM
16
AMI Asset Management
California
$8.5M +$643K +14,462 +9%
Northern Trust
17
Northern Trust
Illinois
$7.5M -$599K -13,460 -8%
Prudential Financial
18
Prudential Financial
New Jersey
$7.42M +$2.89M +64,900 +68%
QBFM
19
QS Batterymarch Financial Management
New York
$5.91M -$481K -10,810 -8%
Invesco
20
Invesco
Georgia
$5.76M -$574K -12,914 -9%
Millennium Management
21
Millennium Management
New York
$5.67M +$1.12M +25,272 +26%
TCIM
22
TIAA CREF Investment Management
New York
$5.13M +$211K +4,746 +4%
Morgan Stanley
23
Morgan Stanley
New York
$5.11M +$1.28M +28,754 +35%
TC
24
TFS Capital
Pennsylvania
$4.9M +$4.14M +93,117 +732%
Charles Schwab
25
Charles Schwab
California
$4.8M -$1.75M -39,320 -27%

ANIK Hedge Fund Activity: Q2 2014 in Review

162 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q2 2014, worth a combined $465M — up 11% from $417M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANIK positions and 15 closed out — a net gain of 9 holders — while 67 added to existing stakes and 49 trimmed.

The largest buyer was Thompson Siegel & Walmsley, adding an estimated $11.7M. The largest seller was Systematic Financial Management, cutting an estimated $26.4M.

  • 162 institutional investors held Anika Therapeutics (ANIK) as of Q2 2014, up from 153 in Q1 2014.
  • Funds reported $465M of Anika Therapeutics stock for Q2 2014, up 11% quarter-over-quarter.
  • 24 funds opened new Anika Therapeutics positions in Q2 2014 and 15 closed out, a net change of +9 holders.
  • The largest Anika Therapeutics buyer in Q2 2014 was Thompson Siegel & Walmsley, an estimated $11.7M added.
  • The largest Anika Therapeutics seller in Q2 2014 was Systematic Financial Management, an estimated $26.4M sold.

Based on aggregated 13F filings for Q2 2014.